Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMBRISENTAN vs AMIKACIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMBRISENTAN vs AMIKACIN: Safety Overview

Metric AMBRISENTAN AMIKACIN
Total FAERS Reports 86,197 11,312
Deaths Reported 10,291 2,114
Death Rate 11.9% 18.7%
Hospitalizations 32,910 4,686
Average Patient Age 59.5 yrs 54.3 yrs
% Female Patients 76.1% 57.4%
FDA Approval Date Apr 10, 2019 Approved Prior to Jan 1, 1982
Manufacturer Sigmapharm Laboratories, LLC Insmed Incorporated
Route ORAL RESPIRATORY (INHALATION)
Marketing Status Prescription Discontinued